Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS

ClinicalTrials.gov ID: NCT00002331

Public ClinicalTrials.gov record NCT00002331. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Open-Label Study of the Tolerability and Efficacy of Clarithromycin and Ethambutol in Combination With or Without Clofazimine for the Treatment of Disseminated MAC (dMAC) in Patients With AIDS

Study identification

NCT ID
NCT00002331
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Abbott
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Ethambutol hydrochloride Drug
  • Clarithromycin Drug
  • Clofazimine Drug

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 1993
Primary completion
Feb 28, 1995
Completion
Feb 28, 1995
Last update posted
Jan 15, 2015

1994 – 1995

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
Kaiser Permanente Med Ctr Los Angeles California 90027
UCD Med Ctr Sacramento California 95817
Kaiser Permanente Med Ctr San Francisco California 94115
Santa Clara Valley Med Ctr San Jose California 951282699
George Washington Univ Med Ctr Washington D.C. District of Columbia 20037
Dr Margaret Fischel Miami Florida 33136
Saint Joseph's Hosp / Infectious Disease Rsch Institute Tampa Florida 33614
Rush Presbyterian - Saint Luke's Med Ctr Chicago Illinois 60612
Tulane Univ Med School New Orleans Louisiana 701122699
Johns Hopkins Univ School of Medicine Baltimore Maryland 21205
Beth Israel Med Ctr New York New York 10003
Mount Sinai Med Ctr New York New York 10029
Univ of North Carolina School of Medicine Chapel Hill North Carolina 275997215
Dr Stephen Hauptman Philadelphia Pennsylvania 19107
Vanderbilt Univ School of Medicine Nashville Tennessee 37212
Univ of Texas Southwestern Med Ctr of Dallas Dallas Texas 75235
Houston Veterans Administration Med Ctr Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002331, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 15, 2015 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002331 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →